Mateusz Antoszewski
@mantoszewski.bsky.social
Postdoctoral Fellow in Hematology/Oncology - Sankaran Lab at Boston Children's Hospital, Broad Institute, Harvard Medical School
Hematopoietic Stem Cells - Genetics - Immunology
Hematopoietic Stem Cells - Genetics - Immunology
Reposted by Mateusz Antoszewski
What protects individuals from developing blood cancers?
Thrilled to share my work in @bloodgenes.bsky.social lab, describing inherited resilience protecting blood stem cells from clonal hematopoiesis by modifying RNA regulation. 🧵👇 (1/n)
www.biorxiv.org/content/10.1...
Thrilled to share my work in @bloodgenes.bsky.social lab, describing inherited resilience protecting blood stem cells from clonal hematopoiesis by modifying RNA regulation. 🧵👇 (1/n)
www.biorxiv.org/content/10.1...
March 27, 2025 at 8:31 PM
What protects individuals from developing blood cancers?
Thrilled to share my work in @bloodgenes.bsky.social lab, describing inherited resilience protecting blood stem cells from clonal hematopoiesis by modifying RNA regulation. 🧵👇 (1/n)
www.biorxiv.org/content/10.1...
Thrilled to share my work in @bloodgenes.bsky.social lab, describing inherited resilience protecting blood stem cells from clonal hematopoiesis by modifying RNA regulation. 🧵👇 (1/n)
www.biorxiv.org/content/10.1...
Reposted by Mateusz Antoszewski
Ukraine Fact Sheet - February 21, 2025: isw.pub/UkraineFacts...
February 21, 2025 at 7:40 PM
Ukraine Fact Sheet - February 21, 2025: isw.pub/UkraineFacts...
Reposted by Mateusz Antoszewski
I am incredibly fortunate to be able to work with this amazing group @hhmi.bsky.social, @bostonchildrens.bsky.social, @danafarber.bsky.social, @harvardmed.bsky.social, @broadinstitute.org!!! 🙏🩸🧬
January 24, 2025 at 2:17 PM
I am incredibly fortunate to be able to work with this amazing group @hhmi.bsky.social, @bostonchildrens.bsky.social, @danafarber.bsky.social, @harvardmed.bsky.social, @broadinstitute.org!!! 🙏🩸🧬
Reposted by Mateusz Antoszewski
Stem cell-like states confer poor outcomes in blood cancer—but what mechanisms drive this and how can they be therapeutically targeted? In our new preprint, we show how a single TF represses one enhancer to maintain a subset of high-risk leukemias: 🧵👇
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
January 2, 2025 at 2:47 PM
Stem cell-like states confer poor outcomes in blood cancer—but what mechanisms drive this and how can they be therapeutically targeted? In our new preprint, we show how a single TF represses one enhancer to maintain a subset of high-risk leukemias: 🧵👇
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Reposted by Mateusz Antoszewski
Had a blast presenting our work today at #ASH24! Very grateful for my mentors and colleagues for their support. Stay tuned very soon for more on this study on how we’ve functionally dissected high-risk leukemias
Outstanding presentation at #ASH24 from @tjflemin.bsky.social from our lab, where he discussed his work on the mechanisms by which MECOM drives high-risk AMLs!!! Congratulations, Travis!!!
December 10, 2024 at 6:52 AM
Had a blast presenting our work today at #ASH24! Very grateful for my mentors and colleagues for their support. Stay tuned very soon for more on this study on how we’ve functionally dissected high-risk leukemias